首页> 外文OA文献 >Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

【2h】

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

机译：转移性阉割抗性前列腺癌新型抗抗原疗法的抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Emmanuel Antonarakis; Karim Boudadi;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer [J] . Karim Boudadi, Emmanuel S. Antonarakis Clinical Medicine Insights: Oncology . 2016,第9期

机译：抵抗去势抵抗性前列腺癌的新型抗雄激素疗法的耐药性
2. Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer [J] . Yasui Masato, Uemura Koichi, Yoneyama Shuko, Japanese journal of clinical oncology. . 2016,第11期

机译：预测使用转移性去势抵抗性前列腺癌的氟他胺替代抗雄激素替代疗法的不良反应
3. Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer. [J] . Jing Li, Andrew J Armstrong Clinical advances in hematology & oncology: H&O . 2015,第5期

机译：要点：在有症状的转移性去势抵抗性前列腺癌，多西他赛或镭中应首先使用哪种？ Radium-223是以骨为主的症状性转移去势抵抗性前列腺癌的首选治疗方法。
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer [O] . Karim Boudadi, Emmanuel S. Antonarakis 2016

机译：抵抗去势抵抗性前列腺癌的新型抗雄激素疗法的耐药性
7. Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer [O] . Masato Yasui, Koichi Uemura, Shuko Yoneyama, 2016

机译：氟胺抗性前列腺癌中氟胺脱氨醛疗法差的差异差的预测因子

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅